Thanks B.B.
I ve been a investor in Cell Genesis , which moved into Biosante and now ANIP , so many years , I was drawn to science of immunotherapy CEGE and although they did not monetize their efforts the science is currently used , I witnessed over last several years ANI gradual growth , our CEO and BOD has accomplished allot , very impressive, & rare. IMO board members here can either contribute their opinion which is welcome we all have them , JTFM & others provides in-depth research that I am sure takes allot of time , greatly appreciated , myself along with others here read through PR material info ANI provides , & opinion , its all good I noticed recently Some new posters site misinformation, either ignorance or set out to mislead investors , it’s not difficult to identify those , it’s obvious. I have only one objective , monetize my investment , I know risk , reward no guarantee, all JMHO